Coadministration has not been studied. Duloxetine is metabolized by CYP2D6 and CYP1A2. Darunavir/cobicistat could potentially increase duloxetine concentration although to a limited extent as cobicistat is a weak inhibitor of CYP2D6. No a priori dosage adjustment is recommended.